JETEMA, Co., Ltd. (KOSDAQ:216080)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,360.00
+220.00 (3.08%)
Apr 10, 2026, 3:30 PM KST
Market Cap265.67B +7.7%
Revenue (ttm)76.90B +12.2%
Net Income-6.60B
EPS-184.00
Shares Out37.21M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume91,680
Average Volume227,110
Open7,180.00
Previous Close7,140.00
Day's Range7,180.00 - 7,430.00
52-Week Range5,370.00 - 11,280.00
Beta1.05
RSI42.26
Earnings DateMay 15, 2026

About JETEMA,

JETEMA, Co., Ltd., a bio venture company, engages in the research and development of medicines and medical devices. It offers clostridium botulinum toxins, fillers, lifting threads for medical treatment, elastin and collagen stimulate solution under Ecolla, and healthy skin care under vitten brand names. The company also provides skin care hyaluronic acid masks. JETEMA, Co., Ltd. was founded in 2009 and is headquartered in Wonju-si, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 265
Stock Exchange KOSDAQ
Ticker Symbol 216080
Full Company Profile

Financial Performance

In 2025, JETEMA,'s revenue was 76.90 billion, an increase of 12.23% compared to the previous year's 68.52 billion. Losses were -6.60 billion, 3407.4% more than in 2024.

Financial Statements